Form EFFECT Enveric Biosciences,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 8, 2025 4:30 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Enveric Biosciences Reports Financial Results and Provides Corporate Update for Second Quarter 2026
- Trading in Pandora A/S shares by Board members, Executives and Associated persons
- Lazard Expands Financial Advisory Business in DACH Region and Appoints Dr. Marco Superina to Lead Investment Banking for Switzerland
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
